share this article

A look at how AI technology such as Deep Learning is being applied to the challenge of drug failure, both in discovery and in clinical trials. Some specific case studies covered in this session include, using clinical trial outcomes to improve estimates of success, examples of how companies are using DL to reduce percentage of trial failures, how is medicinal chemistry and drug design changing and using AI earlier in the discovery cycle to optimize targets and indications for investment.

share this article